We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App





Winner of Qualcomm Tricorder XPrize Unveiled at AACC

By LabMedica International staff writers
Posted on 08 Jun 2017
A highlight of the July 30 - August 3, 2017, AACC Annual Scientific Meeting & Clinical Lab Expo (San Diego, CA, USA) will be the session dedicated to the unveiling of the winner of the Qualcomm Tricorder XPrize (Culver City, CA, USA) competition.

The 10 million USD global competition, which was announced in 2012, challenged 34 research teams to produce a lightweight device (a "tricorder") that consumers could have at their fingertips to diagnose a health condition or monitor their vital signs without the need to consult a medical professional. More...
To qualify the device had to be capable of diagnosing at least 13 health conditions and continuously monitoring five vital signs, all with a consumer-friendly interface and weighing no more than five pounds (2.27 kilograms).

In the science-fictional Star Trek universe, a tricorder was a multifunction hand-held device used for sensor scanning, data analysis, and recording data. The standard tricorder was a general-purpose device used primarily to scout unfamiliar areas, make detailed examination of living things, and record and review technical data. The medical tricorder was used by doctors to help diagnose diseases and collect bodily information about a patient; the key difference between this and a standard tricorder was a detachable hand-held high-resolution scanner stored in a compartment of the tricorder when not in use.

The winner of the top prize of 2.6 million USD was Final Frontier Medical Devices, a Pennsylvania-based team led by Dr. Basil Harris, an emergency medicine physician, and his brother George Harris, a network engineer, for their artificial intelligence-based engine, DxtER, which learns to diagnose medical conditions by integrating learnings from clinical emergency medicine with data analysis from actual patients.

DxtER was designed to monitor the individual's health and diagnose illnesses away from the hospital or doctor's office setting. DxtER functions autonomously, but can also share important information with healthcare providers. At the heart of DxtER is an artificially intelligent engine that learned to diagnose by integrating years of experience in clinical emergency medicine with data analysis from actual patients having a variety of medical conditions and outcomes. Included with DxtER is an assortment of non-invasive sensors custom-designed to collect data about vital signs, body chemistry, and biological functions. The diagnostic engine synthesizes the health data to make a quick and accurate assessment.

Dynamical Biomarkers Group was awarded the second place in the Qualcomm Tricorder XPRIZE competition for their prototype, which links diagnostic algorithms with analytical methodology in a user-friendly device, all controlled through a smartphone.

Final Frontier Medical Devices team member Philip Charron and Dynamical Biomarkers Group team member Dr. Chung-Kang Peng will describe their revolutionary technologies in a major session at the 69th AACC Annual Scientific Meeting.

Related Links:
AACC Annual Scientific Meeting & Clinical Lab Expo
Qualcomm Tricorder XPrize


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Blood Culture Control Panel
Gram-Negative Blood Culture Control Panel
New
Calprotectin Assay
Fecal Calprotectin ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.